https://www.instagram.com/reel/CgeQ5DqgSyv/?utm_source=ig_embed&ig_rid=daafbe6f-3a50-40b1-94e5-430657f8f0eb
Lantern Pharma Announces Data Highlighting The Anti-Tumor Potency Of Drug Candidate LP-184 For Glioblastoma At The Society For Neuro-oncology Annual Meeting
Lantern Pharma Inc. (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and machine learning (“M.L.”) platform to transform the
